Riskpilot← Back to searchSign inGet full accessCBio A/S
A/SActiveCVR 40216642Transformervej 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 20197 employees
Revenue 2024
DKK 4,7M
-15% vs 2023
EBITDA margin
-9.7%
+69% vs 2023
Equity ratio
34.3%
Financial strength
Net profit 2024
DKK -80K
+87% vs 2023
| Revenue | DKK 4,7M | -15% |
| EBITDA | DKK -452K | +69% |
| Net profit | DKK -80K | +87% |
| Total assets | DKK 35,7M | +57% |
| Equity | DKK 12,3M | +114% |
| Employees | 7 | — |
Legal name
CBio A/S
CVR number
40216642
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21. januar 2019
Share capital
DKK 1.946.522
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med to bestyrelsesmedlemmer, af bestyrelsens formand i forening med to bestyrelsesmedlemmer eller af hele bestyrelsen.
Company purpose
Selskabets formål er at drive investering, forskning, handel, fabrikation og hermed forbundet virksomhed primært inden for bioteknologi- og medicinalbranchen
Address
Transformervej 8
Phone
+4531625333
Email
ucordes@cbio.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | -346 | -1.814 | -1.913 | -1.104 | 5.483 | 4.663 |
| Staff expenses | -0 | -3.077 | -7.609 | -8.213 | -6.924 | -5.115 |
| EBITDA | -346 | -4.891 | -9.522 | -9.317 | -1.441 | -452 |
| Depreciation & amort. | -0 | -251 | -1.636 | -1.868 | -0 | -0 |
| EBIT | -346 | -5.141 | -11.159 | -11.185 | -1.441 | -452 |
| Net financials | 0 | -46 | -399 | -592 | -737 | -452 |
| Profit before tax | -346 | -5.188 | -11.558 | -11.778 | -2.178 | -904 |
| Tax | -69 | -1.286 | -3.002 | -2.802 | -1.556 | -825 |
| Net profit | -277 | -3.901 | -8.556 | -8.976 | -622 | -80 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 759 | 15.877 | 18.775 | 14.750 | 22.749 | 35.747 |
| Equity | 723 | 6.822 | 8.265 | -710 | 5.743 | 12.279 |
| Long-term debt | 0 | 5.950 | 7.729 | 9.053 | 8.859 | 6.997 |
| Short-term debt | 36 | 3.105 | 2.781 | 6.407 | 8.147 | 16.471 |
| Total debt | 36 | 9.055 | 10.510 | 15.460 | 17.006 | 23.468 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20192024
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20192024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20192024
Net profit margin
-1.7%
This company
8.1%
Market median
-121% vs market
20192024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20192024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-21 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UC Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CBio Holding ApS | Company | 33.3% | 33.3% | 2024 |
ALFA Ventures ApS | Company | 10.0% | 10.0% | 2021 |
Bildbar ApS | Company | 10.0% | 10.0% | 2019 |
Leroy Capital Fund II Aps | Company | 5.0% | 5.0% | 2021 |
| Individual | 5.0% | 5.0% | 2021 | |
RH Fisker Holding Aps | Company | 5.0% | 5.0% | 2024 |
ALFA DEVELOPMENT A/S | Company | 5.0% | 5.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Leroy Capital Fund II Aps
CBio A/S Board members of CBio A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrik Cordes | Management | 0 companies |
| Christian Henri Leroy | Board of Directors | 0 companies |
| Pernille Cordes | Board of Directors | 0 companies |
| Karin Cecilia Hultén | Board of Directors | 0 companies |
| Else Beth Trautner | Chairman | 0 companies |
| Julie Franziska Hare Cordes | Board of Directors | 0 companies |
| Henriette Just Hare Cordes | Chairman | 0 companies |
| Lars Rabe Tønnesen | Board of Directors | 0 companies |
| Andreea Ioana Kaiser | Board of Directors | 0 companies |